A detailed history of Nuveen Asset Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 39,178 shares of BIO stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,178
Previous 59,409 34.05%
Holding current value
$13 Million
Previous $16.2 Million 19.21%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $5.34 Million - $6.97 Million
-20,231 Reduced 34.05%
39,178 $13.1 Million
Q2 2024

Aug 09, 2024

SELL
$268.26 - $339.48 $8.6 Million - $10.9 Million
-32,068 Reduced 35.06%
59,409 $16.2 Million
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $986,836 - $1.14 Million
3,245 Added 3.68%
91,477 $31.6 Million
Q4 2023

Feb 14, 2024

SELL
$269.37 - $365.04 $801,375 - $1.09 Million
-2,975 Reduced 3.26%
88,232 $28.5 Million
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $4.1 Million - $4.95 Million
-11,707 Reduced 11.38%
91,207 $32.7 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $1.28 Million - $1.73 Million
3,560 Added 3.58%
102,914 $39 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $21.2 Million - $25.5 Million
50,661 Added 104.04%
99,354 $47.6 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $10.9 Million - $14.1 Million
-31,010 Reduced 38.91%
48,693 $20.5 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $599,493 - $818,416
-1,453 Reduced 1.79%
79,703 $33.2 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $255,018 - $328,438
550 Added 0.68%
81,156 $40.2 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $5.04 Million - $7.06 Million
9,599 Added 13.52%
80,606 $46.8 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $8.25 Million - $9.25 Million
11,645 Added 19.62%
71,007 $53.7 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $1.66 Million - $2.08 Million
-2,519 Reduced 4.07%
59,362 $44.3 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $20.4 Million - $23 Million
-35,385 Reduced 36.38%
61,881 $39.9 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $9.89 Million - $12 Million
18,073 Added 22.82%
97,266 $55.6 Million
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $11.4 Million - $14.3 Million
22,265 Added 39.11%
79,193 $46.2 Million
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $1.12 Million - $1.32 Million
2,470 Added 4.54%
56,928 $29.3 Million
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $3.44 Million - $5.07 Million
-10,282 Reduced 15.88%
54,458 $24.6 Million
Q1 2020

May 14, 2020

SELL
$320.01 - $409.07 $2.15 Million - $2.75 Million
-6,734 Reduced 9.42%
64,740 $22.7 Million
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $6.66 Million - $7.8 Million
-20,838 Reduced 22.57%
71,474 $26.4 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $3.07 Million - $3.48 Million
10,076 Added 12.25%
92,312 $30.7 Million
Q2 2019

Aug 15, 2019

BUY
$286.93 - $312.59 $23.6 Million - $25.7 Million
82,236 New
82,236 $25.7 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.